ANL
Price
$1.73
Change
-$0.04 (-2.26%)
Updated
Oct 3 closing price
Capitalization
63.84M
58 days until earnings call
JAZZ
Price
$139.48
Change
+$2.27 (+1.65%)
Updated
Oct 3 closing price
Capitalization
8.46B
30 days until earnings call
Interact to see
Advertisement

ANL vs JAZZ

Header iconANL vs JAZZ Comparison
Open Charts ANL vs JAZZBanner chart's image
Adlai Nortye
Price$1.73
Change-$0.04 (-2.26%)
Volume$2.21K
Capitalization63.84M
Jazz Pharmaceuticals
Price$139.48
Change+$2.27 (+1.65%)
Volume$1.05M
Capitalization8.46B
ANL vs JAZZ Comparison Chart in %
ANL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANL vs. JAZZ commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANL is a Hold and JAZZ is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (ANL: $1.73 vs. JAZZ: $139.48)
Brand notoriety: ANL and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANL: 22% vs. JAZZ: 131%
Market capitalization -- ANL: $63.84M vs. JAZZ: $8.46B
ANL [@Biotechnology] is valued at $63.84M. JAZZ’s [@Biotechnology] market capitalization is $8.46B. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANL’s FA Score shows that 1 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • ANL’s FA Score: 1 green, 4 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, ANL is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANL’s TA Score shows that 2 TA indicator(s) are bullish while JAZZ’s TA Score has 4 bullish TA indicator(s).

  • ANL’s TA Score: 2 bullish, 4 bearish.
  • JAZZ’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, JAZZ is a better buy in the short-term than ANL.

Price Growth

ANL (@Biotechnology) experienced а +0.58% price change this week, while JAZZ (@Biotechnology) price change was +9.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

ANL is expected to report earnings on Dec 03, 2025.

JAZZ is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($8.46B) has a higher market cap than ANL($63.8M). JAZZ YTD gains are higher at: 13.260 vs. ANL (-35.573). JAZZ has higher annual earnings (EBITDA): 372M vs. ANL (-49.89M). JAZZ has more cash in the bank: 1.67B vs. ANL (98M). ANL has less debt than JAZZ: ANL (39.5M) vs JAZZ (5.43B). JAZZ has higher revenues than ANL: JAZZ (4.09B) vs ANL (5M).
ANLJAZZANL / JAZZ
Capitalization63.8M8.46B1%
EBITDA-49.89M372M-13%
Gain YTD-35.57313.260-268%
P/E RatioN/A15.38-
Revenue5M4.09B0%
Total Cash98M1.67B6%
Total Debt39.5M5.43B1%
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
75
SEASONALITY SCORE
1..100
6

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANLJAZZ
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
72%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
59%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
65%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 4 days ago
60%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 11 days ago
57%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
ANL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBIOX22.940.22
+0.97%
Fidelity Select Biotechnology
CWMAX67.210.17
+0.25%
American Funds Washington Mutual 529A
BPAVX34.110.07
+0.21%
Boston Partners All Cap Value Inv
BRWJX29.40-0.12
-0.41%
MFS Blended Research Growth Eq I
RYSIX562.13-3.23
-0.57%
Rydex Electronics Inv

ANL and

Correlation & Price change

A.I.dvisor tells us that ANL and FGHQF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANL and FGHQF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANL
1D Price
Change %
ANL100%
-2.54%
FGHQF - ANL
25%
Poorly correlated
N/A
MOLN - ANL
23%
Poorly correlated
+0.02%
NVCT - ANL
21%
Poorly correlated
-1.07%
JAZZ - ANL
21%
Poorly correlated
+1.65%
VCEL - ANL
21%
Poorly correlated
+2.92%
More

JAZZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAZZ has been loosely correlated with BMRN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if JAZZ jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAZZ
1D Price
Change %
JAZZ100%
+1.65%
BMRN - JAZZ
45%
Loosely correlated
-0.25%
AMLX - JAZZ
43%
Loosely correlated
+0.98%
TECH - JAZZ
43%
Loosely correlated
+1.39%
FTRE - JAZZ
41%
Loosely correlated
-1.56%
ROIV - JAZZ
40%
Loosely correlated
+1.19%
More